<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05023135</url>
  </required_header>
  <id_info>
    <org_study_id>CT-2021-01--CSP-10</org_study_id>
    <nct_id>NCT05023135</nct_id>
  </id_info>
  <brief_title>DeepView SnapShot Portable (DV-SSP): Device Training Study</brief_title>
  <official_title>DeepView SnapShot Portable (DV-SSP): Device Training Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SpectralMD</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>SpectralMD</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to continue development and validation of an algorithm for burn&#xD;
      healing assessment by the Spectral MD DeepView device and provide burn healing potential&#xD;
      assessment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 7, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Predict area of severe burn, using measurement tools such as the Pearson Correlation Coefficient</measure>
    <time_frame>3 weeks</time_frame>
    <description>Test that the Burn Segmentation Algorithm's predicted severe burn area (i.e., deep second degree and third degree) within an image of a burn injury, will be equivalent to the true area of severe burn as determined by the expert panel. The analysis for this study would only include data obtained from participants in the study.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Burns</condition>
  <condition>Wound Heal</condition>
  <arm_group>
    <arm_group_label>Subjects with Thermal Burn Injury</arm_group_label>
    <description>An initial imaging with the DV-SSP would be completed at the Study Site within 72 hours of suffering a thermal burn injury.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DeepView SnapShot Portable (DV-SSP)</intervention_name>
    <description>DV-SSP assistive imaging to collect observational data</description>
    <arm_group_label>Subjects with Thermal Burn Injury</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects enrolled in this study will be recruited at the designated Study Site within 72&#xD;
        hours of suffering a thermal burn injury. Adult and pediatric Subjects with burns from one&#xD;
        or more of the defined burn severities will be enrolled. All Subjects must meet the&#xD;
        specified inclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Willing and able to give informed consent or have a Legally Authorized Representative&#xD;
             (LAR) able to do so;&#xD;
&#xD;
          -  Life expectancy &gt; 6 months;&#xD;
&#xD;
          -  Thermal burn mechanism (flame, scald, or contact);&#xD;
&#xD;
          -  The Study Burn(s) occurred less than 72 hours prior to the time of first imaging; and&#xD;
&#xD;
          -  Minimum burn wound size for adult or pediatric patients is 0.5% TBSA per region&#xD;
&#xD;
          -  For adult Subjects: Have 2 - 4 regions of their clinical burn(s) that meet the&#xD;
             criteria for a Study Burn.&#xD;
&#xD;
          -  For pediatric Subjects: Have 1 - 4 regions of their clinical burn(s) that meet the&#xD;
             criteria for a Study Burn&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or&#xD;
             joints;&#xD;
&#xD;
          -  Subject has burns involving &gt; 50% total body surface area (TBSA);&#xD;
&#xD;
          -  Sepsis at the time of enrollment;&#xD;
&#xD;
          -  Immunosuppression/radiation/chemotherapy &lt; 3 months prior to enrollment;&#xD;
&#xD;
          -  Concurrent use of investigational products with a known effect on the burn sites;&#xD;
             and/or&#xD;
&#xD;
          -  Any condition that in the opinion of the Investigator may prevent compliance with the&#xD;
             study requirements or compromise subject safety.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mary Regan, PhD</last_name>
    <phone>727 385 3904</phone>
    <email>regan@spectralmd.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medstar Washington Hospital</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mounica B.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center New Orleans</name>
      <address>
        <city>New Orleans</city>
        <state>Louisiana</state>
        <zip>70112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shana L</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MGH Outpatient Burn Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenic A.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 20, 2021</study_first_submitted>
  <study_first_submitted_qc>August 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 26, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

